Evidence map›Paper›PMID 41096855›Full record

ArticleInternational journal of molecular sciences2025

A High-Throughput Sequencing Strategy for Clinical Repertoire Profiling of T Cell Receptor Beta Chain: Development and Reference Values Across Healthy Adults, Paediatrics, and Cord Blood Units.

Emma Enrich, Mireia Antón-Iborra, Carlos Hobeich, Rut Mora-Buch, Ana Gabriela Lara-de-León, Alba Parra-Martínez, Belén Sánchez, Francisco Vidal, Pere Soler-Palacin, Francesc Rudilla

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Emma EnrichImmunogenetics and Histocompatibility Laboratory, Banc de Sang i Teixits (Blood and Tissue Bank, BST), 08005 Barcelona, Catalonia, Spain.ORCID 0000-0001-9183-1333
Mireia Antón-IborraImmunogenetics and Histocompatibility Laboratory, Banc de Sang i Teixits (Blood and Tissue Bank, BST), 08005 Barcelona, Catalonia, Spain.ORCID 0000-0002-0630-5222
Carlos HobeichTransfusional Medicine Group, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, Catalonia, Spain.
Rut Mora-BuchTransfusional Medicine Group, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, Catalonia, Spain.ORCID 0000-0002-0117-0007
Ana Gabriela Lara-de-LeónAdvanced & Cell Therapy Services, Banc de Sang i Teixits (Blood and Tissue Bank, BST), 08005 Barcelona, Catalonia, Spain.ORCID 0000-0002-2884-8228
Alba Parra-MartínezInfection and Immunity in Pediatric Patients-Vall d'Hebron Research Institute, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Catalonia, Spain.
Belén SánchezInfection and Immunity in Pediatric Patients-Vall d'Hebron Research Institute, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Catalonia, Spain.
Francisco VidalTransfusional Medicine Group, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, Catalonia, Spain.ORCID 0000-0001-8089-4945
Pere Soler-PalacinInfection and Immunity in Pediatric Patients-Vall d'Hebron Research Institute, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Catalonia, Spain.ORCID 0000-0002-0346-5570
Francesc RudillaImmunogenetics and Histocompatibility Laboratory, Banc de Sang i Teixits (Blood and Tissue Bank, BST), 08005 Barcelona, Catalonia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T cell receptor (TCR) profiling using next-generation sequencing (NGS) enables high-throughput, in-depth analysis of repertoire diversity, offering numerous clinical applications. We developed a DNA-based strategy to analyse the TCRβ-chain using NGS and established reference values for T cell repertoire characteristics in 74 healthy donors, including 44 adults, 20 paediatrics, and 10 cord blood units (CBUs). Additionally, four paediatric patients with combined immunodeficiency (CID) or severe CID (SCID) due to deleterious mutations in recombination activating genes (RAG) were analysed. The developed strategy demonstrated high specificity, reproducibility, and sensitivity, and all functional variable and joining genes were detected with minimal PCR bias. All donors had a Gaussian-like distribution of complementary-determining region 3 length, with lower presence of non-templated nucleotides and higher proportion of non-functional clonotypes in CBUs. Both CBUs and paediatrics showed greater convergence and TCRβ diversity was significantly lower in adults and donors with cytomegalovirus-positive serostatus. Finally, an analysis of paediatric patients with RAG-SCID/CID showed significantly shorter CDR3 region length and lower repertoire diversity compared to healthy paediatrics. In summary, we developed a reliable and feasible TCRβ sequencing strategy for application in the clinical setting, and established reference values that could assist in the diagnosis and monitoring of pathological conditions affecting the T cell repertoire.

Indexed as

Fetal BloodHigh-Throughput Nucleotide SequencingReceptors, Antigen, T-Cell, alpha-betaAdolescentAdultChildChild, PreschoolFemaleHumansMaleMiddle AgedReference ValuesSevere Combined ImmunodeficiencyYoung AdultReceptors, Antigen, T-Cell, alpha-betamolecular diagnosticmolecular methodologiesnext-generation sequencing analysisT cell receptor

Identifiers

PMID41096855
PMCPMC12525236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.